Table 2.
Québec Vaccination Registry information and self-reported vaccination status during the initial telephone follow-up of participants whose emergency department index visit occurred between March 24, 2020, and December 25, 2021 (n=1361).
|
|
Québec Vaccination Registry, n (%) | Self-reported vaccination status, n (%) | |||
| Vaccination status | |||||
|
|
Yes (at least 1 dose) | 913 (67.1) | 932 (68.5) | ||
|
|
No (no dose given) | 448 (32.9) | 429 (31.5) | ||
|
|
Unknown or not assessed | 0 (0) | 0 (0) | ||
| First vaccine brand | |||||
|
|
Pfizer-BioNTech | 707 (51.9) | 689 (50.6) | ||
|
|
Moderna | 162 (11.9) | 158 (11.6) | ||
|
|
AstraZeneca or Covishield | 42 (3.1) | 42 (3.1) | ||
|
|
Johnson & Johnson | <5 (<0.4) | <5a (<0.4) | ||
|
|
Unknown, but vaccinated | 0 (0) | 37 (2.7) | ||
|
|
Unknown or not vaccinated | 448 (32.9) | 433 (31.8) | ||
| Number of vaccines doses | |||||
|
|
0 | 448 (32.9) | 429 (31.5) | ||
|
|
1 | 366 (26.9) | 368 (27) | ||
|
|
2 | 501 (36.8) | 511 (37.5) | ||
|
|
3 | 46 (3.4) | 53 (3.9) | ||
aCells with fewer than 5 individuals could not be presented as requested by the ethics committee.